Note 11 - Related Party Transactions

Two of the Company’s Directors provide consulting, scientific and research and advisory services to the Company. During the fourth quarter of the year ended December 31, 2017, the Company modified the compensation terms under the agreements to compensate Dr. Cohen and Dr. Barzilai for their ongoing consulting, scientific and research and advisory services at an annual rate of $20,000 per individual. In addition, both Dr. Barzilai and Dr. Cohen would receive a fee for serving on the Company’s Board of Directors. During the second quarter of the year ended December 31, 2018, the Company modified the compensation terms to pay each Director board fees only. During the years ended December 31, 2018 and 2017, consulting and board fees paid to each Director totaled $58,334 and $46,500, respectively. As of December 31, 2018, and 2017, no amounts were owed to either Director.